Navigation Links
Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress
Date:10/10/2007

Building upon continued success, company offers new platform for general

surgical procedures

SUNNYVALE, Calif., Oct. 10 /PRNewswire/ -- Starion Instruments, a leading surgical device company, launched the TLS3 Tissue Ligating Shears at the American College of Surgeons 93rd Annual Clinical Congress in New Orleans this week. With the introduction of this new platform, Starion is building upon its success in the cardiovascular and otolaryngological markets to provide an essential solution for general surgical, gynecological and urological procedures.

Unlike conventional products that use monopolar, bipolar or ultrasonic energy as modes of operation, the TLS3 features Starion's proprietary tissue welding technology, which focuses thermal energy to simultaneously seal and divide soft tissue. This reduces thermal spread, which minimizes the risk of inadvertent collateral damage.

"Since the response to our technology by cardiovascular and otolaryngological surgeons has been extremely positive, we've taken this step to expand into the general surgical, gynecological and urological spaces," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "With the TLS3, Starion now offers a complete platform that provides surgeons with the power and precision to quickly and effectively perform a variety of surgical procedures."

The TLS3 features enhanced sealing and dissecting capabilities, an ergonomic handle design, longer more tapered jaws, and two-speed finger control for unparalleled performance in open and minimally invasive surgical procedures. Three lengths, 14cm, 23cm and 35cm, provide improved sealing and dividing of larger vessels frequently encountered in general surgical, gynecological and urological procedures. Along with the TLS3, Starion is introducing a new Universal Power Supply that is compatible with the company's entire product line.

"The Starion TLS3 is the most versatile tissue sealing device on the market," said Dr. Paul G. Curcillo II, MD, F.A.C.S., associate professor and vice chair of the Department of Surgery and director of robotic and minimally invasive surgery, Drexel University College of Medicine. "Because the TLS3 has two active jaws, I can use it as a dissector and a grasper, as well as a cutter and sealer, which means I have fewer instrument exchanges through the abdominal wall during surgery. Additionally, the TLS3 has a comfortable handle design and a compact power supply making it easy for me to use and my operating room staff to set-up."

Starion will be showcasing the new TLS3 at the American College of Surgeons 93rd Annual Clinical Congress in New Orleans from October 7th - 11th at booth number 446.

About Starion Instruments

Starion Instruments designs, manufactures and sells surgical instruments that simultaneously seal and divide tissue during surgery, employing a proprietary tissue welding technology, which requires no electricity or ultrasonic energy across tissue. Starion products are in use worldwide in a variety of cardiac, general surgery, gynecology, otolaryngology and urology procedures. For more information, visit the company's website at http://www.starioninstruments.com.


'/>"/>
SOURCE Starion Instruments
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Musical Instruments Pleasing To The Ear But Rough On The Skin
2. Sterilization Of Dental Instruments Is Inadequate, Says Study
3. Contaminated Surgical Instruments Increase Risk Of Infections
4. Glaxo launches pills to help smokers quit in 7-12 weeks
5. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
6. Dr Reddy’s Laboratories launches Hyalosy
7. Serum Institute Launches New Tetanus-Diphtheria Vaccine
8. Scottish Health Minister Launches Organ Donor Plan
9. GlaxoSmithKline launches diabetes and cancer drugs
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Pfizer Launches Viagra For Lung Disease In UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... among Pittsburgh-area schoolchildren has found that more than 40 percent of participating fifth-grade ... MD , Director of Allergy and Asthma Clinical Research in the Division of ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... ... May 05, 2016 , ... The 2016 Nike Soccer Camp will be directed ... university coaching staff. Together they bring their winning Vandals coaching philosophy to young athletes. ... ages 5-13, and high school players. Session dates are as follows: , Youth Day ...
(Date:5/5/2016)... ... May 05, 2016 , ... When stiff and achy joints ... the pain that’s a common osteoarthritis (OA) symptom. Yet, numerous clinical studies point ... arthritis. , “Physical therapy exercises are commonly prescribed to individuals with osteoarthritis ...
(Date:5/5/2016)... ... ... Lung Institute will celebrate its three-year anniversary on May 14 by giving away ... month of May. To date, the Lung Institute has treated over 2,000 people at their ... testament to the success of this treatment and to the patients who refuse to give ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... Research and Markets has announced the addition ... Outlook 2020" report to their offering. ... has improved significantly in past years due to which ... years. Many cancer drugs have been developed by utilization ... expected to be developed with its help. They are ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: